CELDAZ DACARBAZINE INJECTION

Get a Price/Quote

CELDAZ DACARBAZINE INJECTION Specification

Pacakaging (Quantity Per Box)
1 vial per box

Indication
Treatment of certain types of cancer including malignant melanoma and Hodgkins lymphoma

Dosage Form
Lyophilized powder for injection

Salt Composition
Dacarbazine

Origin of Medicine
Allopathic

Drug Type
Prescription drug

Ingredients
Dacarbazine

Physical Form
Injection

Function
Antineoplastic (cancer treatment)

Recommended For
Anticancer therapy, Hodgkins disease, Malignant melanoma, Soft tissue sarcoma

Dosage
As prescribed by physician

Dosage Guidelines
Administer intravenously under medical supervision

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protected from light

Shelf Life
24 months from manufacturing date

Prescription Status
Prescription only

Contraindications
Hypersensitivity to dacarbazine or any excipients

Brand Name
CELDAZ

Administration Route
Intravenous use only

Reconstitution Solvent
Sterile Water for Injection

Strength
200 mg / 500 mg options (verify pack)

Color
White to off-white

CELDAZ DACARBAZINE INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About CELDAZ DACARBAZINE INJECTION

Celdaz 500mg Injection

Specifications:-

Strength:200 mg & 500 mg
Form:Injection
Packaging Size:pack in form of 1 vial
Manufacturer:Celon Lab
Composition:Dacarbazine
Brand:CELDAZ

Note :- CELDAZ Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug................

Precise Anticancer Therapy

CELDAZ Dacarbazine Injection provides targeted anticancer treatment for adults diagnosed with Hodgkins disease, malignant melanoma, or soft tissue sarcoma. The medications lyophilized form ensures stability and effective dosing when reconstituted before intravenous use.

Safe Administration and Handling

CELDAZ is intended exclusively for intravenous use, requiring reconstitution with Sterile Water for Injection. The medicine must be handled and administered by healthcare professionals in a controlled clinical environment to maximize therapeutic effect and limit risks.

Quality Assurance and Packaging

Each vial is carefully packaged to preserve integrity during transport and storage. With a shelf life of 24 months, CELDAZ remains effective when kept below 25C and protected from light, ensuring reliable availability for healthcare providers and patients.

FAQs of CELDAZ DACARBAZINE INJECTION:

Q: How should CELDAZ Dacarbazine Injection be administered?

A: CELDAZ is administered as an intravenous injection after reconstitution with Sterile Water for Injection. It must be given under strict medical supervision in a healthcare setting to ensure correct dosing and monitor for potential side effects.

Q: What conditions are treated with CELDAZ Dacarbazine Injection?

A: CELDAZ is recommended as an antineoplastic therapy for certain cancers, specifically malignant melanoma, Hodgkins lymphoma, and soft tissue sarcoma in adults. It is prescribed after evaluation by an oncologist.

Q: When is CELDAZ Dacarbazine Injection contraindicated?

A: CELDAZ should not be used in patients with known hypersensitivity to dacarbazine or any of the excipients in the formulation. A physicians thorough review is necessary before starting therapy to identify any contraindications.

Q: Where should CELDAZ Dacarbazine Injection be stored?

A: CELDAZ vials should be stored below 25C and protected from light. Proper storage maintains the medications efficacy throughout its 24-month shelf life from manufacturing date.

Q: What process is involved in preparing CELDAZ for use?

A: The lyophilized powder must be reconstituted using Sterile Water for Injection before intravenous administration. This process is performed by qualified healthcare professionals to ensure safety and correct concentration.

Q: What are the benefits of using CELDAZ Dacarbazine Injection for cancer treatment?

A: CELDAZ offers targeted action against specific cancers, making it a valuable component in oncology therapy for malignant melanoma, Hodgkins disease, and soft tissue sarcoma. Its controlled administration enhances treatment outcomes and patient safety.

Tell us about your requirement